CELZ — Creative Medical Technology Holdings Share Price
0.000.00%
Last trade - 00:00- $5.09m
- -$0.85m
- $0.01m
- 29
- 19
- 42
- 20
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.8 | ||
| Price to Tang. Book | 0.88 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 463.05 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -90.57% | ||
| Return on Equity | -65.85% | ||
| Operating Margin | -52216.91% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.16 | 0.09 | 0.09 | 0.01 | 0.01 | n/a | n/a | -41.85% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Directors
- Timothy Warbington PRE (58)
- Donald Dickerson CFO (56)
- Michael Finger DRC
- Susan Snow DRC
- Bruce Urdang DRC
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 3rd, 1998
- Public Since
- May 1st, 2009
- No. of Shareholders
- 75
- No. of Employees
- 4
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 2,585,532
- Address
- 211 E. Osborn Rd., PHOENIX, 85012
- Web
- https://creativemedicaltechnology.com/
- Phone
- +1 4803992822
- Auditors
- Haynie & Co.
Upcoming Events for CELZ
Q1 2025 Creative Medical Technology Holdings Inc Earnings Release
Creative Medical Technology Holdings Inc Annual Shareholders Meeting
Q2 2025 Creative Medical Technology Holdings Inc Earnings Release
Similar to CELZ
Abeona Therapeutics
NASDAQ Capital Market
ABVC Biopharma
NASDAQ Capital Market
Acesis Holdings
NASDAQ Capital Market
Achieve Life Sciences
NASDAQ Capital Market
Aclarion
NASDAQ Capital Market
FAQ
What is the Creative Medical Technology Holdings share price?
As of Today at 20:06 UTC, shares in Creative Medical Technology Holdings are trading at $1.97. This share price information is delayed by 15 minutes.
How has the Creative Medical Technology Holdings share price performed this year?
Shares in Creative Medical Technology Holdings last closed at $1.97 and the price had moved by -60.56% over the past 365 days. In terms of relative price strength the Creative Medical Technology Holdings share price has underperformed the S&P500 Index by -62.92% over the past year.
What are the analyst and broker recommendations for Creative Medical Technology Holdings?
The overall consensus recommendation for Creative Medical Technology Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Creative Medical Technology Holdings dividend yield?
Creative Medical Technology Holdings does not currently pay a dividend.
Does Creative Medical Technology Holdings pay a dividend?
Creative Medical Technology Holdings does not currently pay a dividend.
When does Creative Medical Technology Holdings next pay dividends?
Creative Medical Technology Holdings does not currently pay a dividend.
How do I buy Creative Medical Technology Holdings shares?
To buy shares in Creative Medical Technology Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Creative Medical Technology Holdings?
As of the previous close price of $1.97, shares in Creative Medical Technology Holdings had a market capitalisation of $5.09m.
Where are Creative Medical Technology Holdings shares listed?
Here are the trading details for Creative Medical Technology Holdings:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: CELZ
What kind of share is Creative Medical Technology Holdings?
Based on an overall assessment of its quality, value and momentum Creative Medical Technology Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Creative Medical Technology Holdings share price forecast for 2025?
The analyst consensus target price for shares in Creative Medical Technology Holdings is $26.00. That is 1219.8% above the last closing price of $1.97.
Analysts covering Creative Medical Technology Holdings currently have a consensus Earnings Per Share (EPS) forecast of -$2.03 for the next financial year.
Find out moreWhat is the trend in the Creative Medical Technology Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Creative Medical Technology Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -50.5%.
As of the last closing price of $1.97, shares in Creative Medical Technology Holdings were trading -38.7% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Creative Medical Technology Holdings PE Ratio?
The Creative Medical Technology Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.97.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Creative Medical Technology Holdings?
Creative Medical Technology Holdings' management team is headed by:
- Timothy Warbington - PRE
- Donald Dickerson - CFO
- Michael Finger - DRC
- Susan Snow - DRC
- Bruce Urdang - DRC